Table 4.
Risk evaluation for AFM1 via consumption of brukina samples obtained from Greater Accra region of Ghana.
Locality | Av. body wgt. (kg) | Estimated daily intake (EDI) (ng/kg bw/day) | Hazard Index (H.I) | Cancer risk (cases/100,000 person/yr) | |
---|---|---|---|---|---|
Nima | Infants (0–11 mths) | 2.9 | 0.64 | 3.2 | 0.0206 |
Toddlers (12–35 mths) | 9.8 | 0.38 | 1.90 | 0.0122 | |
Children (36 mths–10 yrs) | 26 | 0.14 | 0.70 | 4.52 × 10–3 | |
Adolescents (11–17 yrs) | 46.25 | 0.079 | 0.40 | 2.55 × 10–3 | |
Adults (18–64 yrs) | 60.7 | 0.061 | 0.31 | 1.97 × 10–3 | |
Madina | Infants (0–11 mths) | 2.9 | 1.185 | 5.93 | 0.038 |
Toddler (12–35 mths) | 9.8 | 0.70 | 3.50 | 0.02261 | |
Children (36 mths–11 yrs) | 26 | 0.264 | 1.30 | 8.52 × 10–3 | |
Adolescents (11–17 yrs) | 46.25 | 0.149 | 0.75 | 4.813 × 10–3 | |
Adults (18–64 yrs) | 60.7 | 0.113 | 0.57 | 3.65 × 10–3 |
Mean of AFM1—Nima = 0.27 µg/kg, Madina = 0.5017 µg/kg.
Daily intake of milk for infants was halved (0.5 × 0.0137 kg).
Average body weights were obtained from the different ranges referenced by the authors.
Average potency for AFM1 = 0.0323.
1 µg = 1000 ng.
H.I Hazard Index.